Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study
- Resource Type
- Article
- Source
- In
eClinicalMedicine June 2023 60 - Subject
- Language
- ISSN
- 2589-5370